3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
23
Myelodysplastic Syndromes
14
Leukemia, Myelomonocytic, Chronic
7
Myeloproliferative Disorders
4
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Biphenotypic, Acute
2
Anemia, Refractory, with Excess of Blasts
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Systemic Mastocytosis With an Associated Hematologic Neoplasm
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Neurofibrosarcoma
1
Neuroendocrine Tumors
1
Mesothelioma, Malignant
1
Mesothelioma
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Chronic-Phase
1
Hodgkin Disease
1
GATA2 Deficiency
1
Cytopenia
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
BRCA1 Mutation
1
Interventions
pertuzumab
1
Validation Studies as Topic
1
Trastuzumab
1
Tape Recording
1
Surgical Procedures, Operative
1
Radiotherapy
1
Opdualag
1
Nivolumab
1
Injections, Subcutaneous
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Patient Preference
×
decitabine and cedazuridine drug combination
×
1 year
×
Clear all
No trials found.